Add-on treatment with mezigdomide significantly delayed cancer progression among people with hard-to-treat myeloma in a Phase 3 clinical trial, according to interim data announced…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
There’s a nylon duffel bag that remains by my front door — but it isn’t for the gym, grocery shopping, or anything like that. The…
The U.S. Food and Drug Administration (FDA) has approved the combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) for treating certain…
Discussion
Is this morbid? I have a new habit after my multiple myeloma diagnosis. When I see a headline that says someone famous has cancer,…
Discussion
We are told different stories about what is involved in caregiving and who a caregiver is supposed to be. These tales are usually pristine and…
March is Myeloma Action Month (MAM), and organizations around the world are participating to support patients, families, and caregivers who live with myeloma. This year,…
